Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Biden adds weight loss drug Ozempic
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
High-dose Wegovy leads to substantial weight loss in trial
Novo Nordisk’s Wegovy Achieves Weight-Loss of 20.7% at Higher Dose, Study Says
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, without experiencing an increase in side-effects.
High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound
A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with Zepbound.
Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the results fell short of the weight loss achieved with Eli Lilly's rival drug Zepbound,
16h
Websites selling compounded weight-loss drugs fail to inform patients of risks, research shows
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
10h
on MSN
Ozempic, Wegovy are among 15 drugs selected for Medicare’s price negotiations
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
5d
'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
To go dark on Sunday
Cabinet approves Gaza deal
To skip Trump’s inauguration
Opposes Fani Willis' bid
Polar vortex to freeze US
Sign partnership treaty
Denied bail in assault case
Senate confirmation hearing
US drops corruption case
FTC sues PepsiCo
Pence advocates for Taiwan
New Pompeii excavation
Bitcoin soars past $100K
Liable for defaming veteran
To fill Vance’s Senate seat
Former NBA champion dies
CA battery storage plant fire
Texas abortion pill ruling
Attempted attack sentencing
Khan gets 14-year jail term
Apple halts AI news alerts
Acting legend Plowright dies
Commutes more sentences
Navalny lawyers sentenced
NHTSA probing GM vehicles
Calls for stronger sanctions
More cops in subway system
To negotiate drug prices
Civil rights probe findings
Related topics
Medicare
Ozempic
Novo Nordisk
Presidency of Donald Trump
Eli Lilly and Company
Feedback